Apricus Bio makes Paul Maier director
This article was originally published in Scrip
San Diego-based pharma company Apricus Biosciences has appointed Sequenom CFO Paul Maier to its board of directors. Mr Maier has been at Sequenom since 2009, having previously served as senior vice-president and CFO of Ligand Pharmaceuticals.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.